利润表
SURGERY PARTNERS, INC.
SGRY
业绩概览
点击表格中任意一行将其添加到图表
单位：百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
营业收入
|
- | - | - | - | - | - | - | - | - | 1,145.44 | 959.89 |
|
营业成本
|
- | - | - | - | - | - | 1,407.60 | 1,361.43 | - | 821.20 | 669.33 |
|
毛利润
|
- | - | - | - | - | - | -1,407.60 | -1,361.43 | - | 324.24 | 290.57 |
|
营业费用
|
2,919.20 | 2,765.50 | 2,415.30 | 2,194.10 | 1,922.90 | 1,677.10 | 88.60 | 1,693.62 | 0.00 | 948.96 | 815.14 |
|
研发费用
|
- | - | - | - | - | - | - | - | - | - | - |
|
销售、一般及行政费用
|
118.20 | 138.70 | 120.90 | 102.20 | 104.00 | 97.10 | 88.60 | 93.56 | - | 60.25 | 59.53 |
|
其他营业费用
|
- | - | - | - | - | - | - | - | - | - | - |
|
营业利润
|
-2,919.20 | -2,765.50 | -2,415.30 | -2,194.10 | -1,922.90 | -1,677.10 | -1,496.20 | -3,055.05 | - | -624.71 | -524.57 |
|
营业外收入
|
- | - | - | - | - | - | - | - | - | - | - |
|
利息收入
|
- | - | - | - | - | - | - | - | - | - | - |
|
利息支出
|
- | - | - | - | - | - | - | - | - | - | - |
|
其他营业外收入/支出
|
22.90 | 19.50 | 14.20 | 12.50 | 11.30 | 10.80 | 10.20 | 8.90 | - | 4.76 | 3.78 |
|
税前利润
|
- | - | - | - | - | - | - | - | - | - | - |
|
所得税费用
|
18.00 | 134.60 | -0.30 | 23.30 | 10.50 | -20.10 | 9.50 | 26.46 | - | 7.10 | -148.98 |
|
少数股东损益
|
176.80 | 180.60 | 147.20 | 141.60 | 141.60 | 117.40 | 119.90 | 110.08 | - | 75.63 | 71.42 |
|
净利润
|
-77.90 | -168.10 | -11.90 | -54.60 | -70.90 | -116.10 | -74.80 | -205.71 | - | 9.45 | 1.43 |
补充资料
每股数据、派生项目及其他——不属于利润表
除特别注明外，单位均为百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
折旧与摊销
|
- | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-2,743.20 | -2,612.90 | -2,297.20 | -2,079.30 | -1,824.10 | -1,582.30 | -1,419.70 | -2,987.61 | 0.00 | -585.16 | -490.03 |
|
基本每股收益
|
-0.61 | -1.33 | -0.09 | -0.59 | -1.12 | - | - | -4.96 | - | 0.20 | 0.04 |
|
稀释每股收益
|
-0.61 | -1.33 | -0.09 | -0.59 | -1.12 | - | - | -4.96 | - | 0.20 | 0.04 |
|
加权平均股数
|
127.21 | 126.12 | 125.61 | 91.95 | 72.43 | - | - | 48.03 | - | 48.02 | 36.07 |
|
稀释加权平均股数
|
127.21 | 126.12 | 125.61 | 91.95 | 72.43 | - | - | 48.03 | - | 48.19 | 37.46 |
|
综合收益
|
-96.50 | -220.80 | -30.60 | 53.10 | -41.40 | -126.40 | -103.10 | -228.15 | - | 9.45 | 1.43 |